State of Tennessee, Department of Treasury’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.65M Buy
10,254
+61
+0.6% +$16.2K 0.01% 793
2025
Q4
$2.85M Sell
10,193
-925
-8% -$195K 0.01% 780
2025
Q3
$1.96M Buy
11,118
+167
+2% +$25K 0.01% 934
2025
Q2
$1.51M Sell
10,951
-211
-2% -$31K 0.01% 1004
2025
Q1
$2.01M Sell
11,162
-137
-1% -$23K 0.01% 872
2024
Q4
$1.77M Sell
11,299
-263
-2% -$46.7K 0.01% 967
2024
Q3
$2.1M Buy
+11,562
New +$2.23M 0.01% 906

Other funds holding KRYS

State of Tennessee, Department of Treasury's KRYS Position: Q1 2026 in Review

State of Tennessee, Department of Treasury increased its Krystal Biotech (KRYS) stake by 0.6% in Q1 2026, buying an estimated $16.2K and bringing the position to 10,254 shares worth $2.65M. The position accounts for 0.01% of the portfolio, ranked #793.

State of Tennessee, Department of Treasury first reported a position in KRYS in Q3 2024 and has held it in 7 quarters since. The position peaked at $2.85M in Q4 2025. 367 funds tracked by Wall St. Rank hold KRYS as of Q1 2026.

  • State of Tennessee, Department of Treasury held 10,254 shares of Krystal Biotech worth $2.65M as of Q1 2026.
  • State of Tennessee, Department of Treasury bought 61 Krystal Biotech shares in Q1 2026, an estimated $16.2K.
  • Krystal Biotech made up 0.01% of State of Tennessee, Department of Treasury's portfolio in Q1 2026, its #793 holding.
  • State of Tennessee, Department of Treasury first reported a position in Krystal Biotech in Q3 2024 and has held it in 7 quarters since.
  • State of Tennessee, Department of Treasury's Krystal Biotech position peaked at $2.85M in Q4 2025.
  • 367 funds tracked by Wall St. Rank held Krystal Biotech as of Q1 2026.

Based on State of Tennessee, Department of Treasury's 13F filing for Q1 2026, filed 15 May 2026.